AzTrials
AzTrials

DepressionFDPNCT02021578

A Family Depression Prevention Program

A study testing Family Cognitive Behavioral Prevention and Written information in people with Depression, run by Vanderbilt University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim is to prevent depression in youth and parents in a single, integrated family intervention. Hypothesis 1a: Children in the Family Depression Prevention (FDP) program will have significantly lower levels of anxious/depressive symptoms and fewer onsets of depressive episodes as compared to children in the… Read more about this study

Who is it for?
Ages 9 to 15 years
Conditions the study is for
Depression
What is being tested?
Family Cognitive Behavioral Prevention and Written information
Could I receive a placebo?
No, everyone receives an active treatment
How many people
304 participants
Where
2 sitesUnited States
Study dates
1 Aug 2014to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Parent with a current or history of a depressive disorder within child's life
  • Children ages 9- to 15-years-old

Who cannot join

  • Bipolar I (parent or child)
  • Schizophrenia (parent or child)
  • Current alcohol or drug abuse (parent or child)
  • Conduct disorder; developmental disability (child)
  • Current diagnosis of a depressive disorder (child)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Vanderbilt University

    Nashville, Tennessee, 37203-5721

  • San Diego State University

    San Diego, California, 92120-4913

Other trials in United States

About this study

Official title: Family Cognitive Behavioral Prevention of Depression in Youth and Parents

The primary aim is to prevent depression in youth and parents in a single, integrated family intervention.

Hypothesis 1a: Children in the Family Depression Prevention (FDP) program will have significantly lower levels of anxious/depressive symptoms and fewer onsets of depressive episodes as compared to children in the Written Information (WI) condition.

Hypothesis 1b: In parents, the amount of time in a depressive episode will be significantly lower for those in the FDP program as compared to those in the WI condition.

Read the detailed description

Depression is a major public health problem affecting over 15 million U.S. adults annually and is especially prevalent in those of parenting age. Offspring of depressed parents are at increased risk of depression and therefore are a critical target for preventive interventions. The current study aims to reduce the rate of depression in parents and their children by adopting an innovative, family-based approach to simultaneously preventing depression in at-risk youth and in their affected parents. The rationale for this approach is based on (a) a conceptual model that integrates parenting processes, stress (particularly that which is associated with parental depression), and children's self-regulatory skills in the face of stress, (b) evidence that depression runs in families, (c) promising results from family- and child-focused depression prevention programs, (d) evidence that in adults, cognitive-behavioral therapy (CBT) reduces both depressive episodes and their recurrence, and (e) growing consensus among scientists, clinicians, and policymakers on the need for family-based models of healthcare. This 5- year, two-site randomized controlled trial will test a Family Depression Prevention (FDP) program for children (ages 9-15) and their parents with depressive disorders (past or current). This "dual prevention" approach is a novel synthesis of existing evidence-based intervention techniques drawn from child prevention and adult treatment models. Participating families (N=300) will be randomized to either FDP (10 weekly + 3 monthly sessions) or a written information comparison (WI) condition. All parents and children will be evaluated at pre- and post-intervention, and at 6-, 12-months from baseline.

Conditions
Depression
Being tested
Family Cognitive Behavioral Prevention, Written information
Keywords
Depression, Mood disorder
Medical subject headings
Depression, Mood Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family Cognitive Behavioral PreventionBehavioural

    Also called Cognitive behavioral intervention, Coping skills training, Parent training

    Parent training and cognitive behavioral intervention with parents. Coping skills training with children.

  • Written informationBehavioural

    Also called Psychoeducation, Self-help

    Reading materials about depression

Study groups in NCT02021578
Study groupRoleWhat they receive
Family Cognitive Behavioral PreventionExperimentalA family cognitive behavioral program for parents and children. Parents learn parenting skills and cognitive behavioral techniques for managing depression. Children learn coping skills.
Receives: Behavioral: Family Cognitive Behavioral Prevention
Written InformationActive comparatorFamilies receive written materials about depression and the effects of parental depression on children.
Receives: Behavioral: Written information

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In children, the primary outcome is level of symptoms on the Youth Self-report form.

    For child participants, we will assess change in their levels of symptoms on the Youth Self-report form at 12-month follow-up. T-scores range from 0 to 100; higher scores indicate more symptoms (i.e., worse outcome).

    Measured: twelve months post baseline

Secondary outcomes (3)
  1. In children, level of internalizing and externalizing symptoms on the Child Behavior Checklist completed by parent about the child

    For child participants, we will assess change in their levels of symptoms on the Child Behavior checklist at 12-month follow-up.

    Measured: 12 months

  2. Parents: Patient Health Questionnaire - 9 (PHQ-9)

    Parent participants: The PHQ-9 measures 9 symptoms of depression on a 4-point scale. Scores can range from 0 to 36.

    Measured: 12 months

  3. Children: depressive diagnoses

    Children and parents are interviewed about the child's depressive symptoms with the Longitudinal Interval Follow-up Evaluation, which yields scores 1-6 for each week.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2013 (estimated)
  2. Study start1 Aug 2014
  3. Primary completion30 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
304 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02021578
Sponsor's protocol ID
8482529
Acronym
FDP
Status last verified
Jan 2024
First submitted
19 Dec 2013
Last updated
1 Feb 2024
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: De-identified individual participant data reported in publications will be made available to researchers upon request.

Publications

  • Kado-Walton M, Vreeland A, Henry L, Gruhn M, Compas B, Garber J, Weersing VR. Racial/ethnic differences in parenting behaviors among depressed parents. J Fam Psychol. 2023 Sep;37(6):763-773. doi: 10.1037/fam0001125. Epub 2023 Jun 26.

    PubMed 37358525

Questions about this trial

What is this clinical trial studying?

A study testing Family Cognitive Behavioral Prevention and Written information in people with Depression, run by Vanderbilt University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In children, the primary outcome is level of symptoms on the Youth Self-report form. (time frame: twelve months post baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02021578, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in